Unraveling the therapeutic potential of the LncRNA-dependent noncanonical Hedgehog pathway in cancer

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Acquired resistance to Hedgehog pathway inhibitors has been reported in the clinical setting and upregulation of noncanonical Hedgehog signaling is one of the major underlying mechanisms behind this resistance. As demonstrated in our recent study, greater clinical efficacy might be achieved by focusing on downstream targets of the chemokine-activated noncanonical Hedgehog signaling pathway such as BCAR4 and phospho-GLI2 (Ser149).

Original languageEnglish (US)
Article numbere998900
JournalMolecular and Cellular Oncology
Volume2
Issue number4
DOIs
StatePublished - Oct 2 2015

Keywords

  • BCAR4
  • Hedgehog Gli2
  • Long non-coding RNA
  • breast cancer
  • cancer treatment
  • locked nucleic acid
  • lung metastasis
  • signaling pathway

ASJC Scopus subject areas

  • Molecular Medicine
  • Cancer Research

Fingerprint

Dive into the research topics of 'Unraveling the therapeutic potential of the LncRNA-dependent noncanonical Hedgehog pathway in cancer'. Together they form a unique fingerprint.

Cite this